<DOC>
	<DOCNO>NCT01050855</DOCNO>
	<brief_summary>This Phase II pilot study evaluate engraftment toxicity patient non-malignant disease use reduce intensity condition regimen set allogeneic transplant non malignant disease . Bone Marrow cord blood acceptable stem cell source . Recently , reduce intensity conditioning ( RIC ) regimens used adult patient leukemias pediatric patient non-malignant disease . These regimen well tolerate , result less transplant related morbidity mortality . Stable mixed chimerism , insufficient eradication leukemia , may sufficient cure patient non-malignant disease .</brief_summary>
	<brief_title>Reduced Intensity Conditioning ( RIC ) Regimen Patients With Non-malignant Disorders</brief_title>
	<detailed_description>There two conditioning regimen protocol child &gt; 6 month . Alemtuzumab ( Campath ) , Fludarabine Melphalan use . The regimen differ time dose Alemtuzumab ( Campath ) . The two timing distal intermediate . - Distal campath initiate 22 day prior allogeneic transplant . - Intermediate campath initiate 14 day prior allogeneic transplant . The condition regimen child immunodeficiency &lt; 6 month omits melphalan , substitute two day busulfan . This regimen successfully use UK , successful 3 month old infant CHOP engraft haploidentical donor .</detailed_description>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Hemoglobinopathies</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Alemtuzumab</mesh_term>
	<mesh_term>Melphalan</mesh_term>
	<mesh_term>Busulfan</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>1 . Age &gt; 6 month 25 year 2 . Diseases eligible Distal Alemtuzumab : Immunodysregulation polyendocrinopathy enteropathy Xlinked ( IPEX ) syndrome Sickle cell disease Thalassemia major Bone marrow failure 3 . Diseases eligible Intermediate Alemtuzumab Hemophagocytic lymphohistiocytosis macrophage activation syndrome , severe Langerhans histiocytosis Severe combine immune deficiency , adenosine deaminase deficiency , common variable immunodeficiency WiskottAldrich syndrome 4 . Organ criterion : Cardiac : Echocardiogram shorten fraction &gt; 27 % Renal : Serum creatinine less 1.5 time upper limit normal age Hepatic : liver function test must less 5 time upper limit normal 5 . No active infection Exclusion criterion 1 . Uncontrolled bacterial , fungal viral infection</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Non-malignant disease</keyword>
	<keyword>Immune deficiency</keyword>
	<keyword>Hemoglobinopathies</keyword>
	<keyword>Reduced Intensity Conditioning ( RIC )</keyword>
</DOC>